Pancreatic Cancer Research

ResearcherHarvard UniversityNo recent work listed

Mariam F. Eskander

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8857-3564; OpenAlex author ID A5018740423. Sources: OpenAlex.

Their work

Papers
13 (first author 5, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2016: 4 papers · 2017: 4 papers · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 3 papers · 2023: 1 paper

Papers 13

  1. Association between SMAD4 Mutations and GATA6 Expression in Paired Pancreatic Ductal Adenocarcinoma Tumor Specimens: Data from Two Independent Molecularly-Char… Co-author DOI 10.3390/biomedicines11113058↗
  2. From street address to survival: Neighborhood socioeconomic status and pancreatic cancer outcomes. Co-author DOI 10.1016/j.surg.2021.10.027↗
  3. In search of lost time: Delays in adjuvant therapy for pancreatic adenocarcinoma among under-resourced patient populations. First author DOI 10.1016/j.surg.2022.04.018↗
  4. Access Denied: Inequities in Clinical Trial Enrollment for Pancreatic Cancer. Co-author DOI 10.1245/s10434-021-10868-4↗
  5. Is Neoadjuvant Therapy Sufficient in Resected Pancreatic Cancer Patients? A National Study. Co-author DOI 10.1007/s11605-017-3541-8↗
  6. Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review. First author DOI 10.1002/cncr.30856↗
  7. Neoadjuvant therapy versus upfront surgery for resected pancreatic adenocarcinoma: A nationwide propensity score matched analysis. First author DOI 10.1016/j.surg.2016.08.040↗
  8. Evolution and impact of lymph node dissection during pancreaticoduodenectomy for pancreatic cancer. Co-author DOI 10.1016/j.surg.2016.09.032↗
  9. Regional variation in the treatment of pancreatic adenocarcinoma: Decreasing disparities with multimodality therapy. First author DOI 10.1016/j.surg.2017.03.009↗
  10. A Tale of Two Cities: Reconsidering Adjuvant Radiation in Pancreatic Cancer Care. Co-author DOI 10.1007/s11605-015-2951-8↗
  11. Neoadjuvant therapy versus upfront surgical strategies in resectable pancreatic cancer: A Markov decision analysis. Co-author DOI 10.1016/j.ejso.2016.07.016↗
  12. Early surgical bypass versus endoscopic stent placement in pancreatic cancer. First author DOI 10.1016/j.hpb.2016.05.008↗
  13. Pancreatic adenocarcinoma. Co-author DOI 10.1067/j.cpsurg.2016.01.001↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jennifer F. Tseng · 9 shared papers, 2016–2018 · strength 0.64
  2. Susanna W.L. de Geus · 8 shared papers, 2016–2018 · strength 0.54
  3. Ahmad B. Hamad · 3 shared papers, 2022 · strength 0.50
  4. Allan Tsung · 3 shared papers, 2022 · strength 0.50
  5. Gyulnara G. Kasumova · 5 shared papers, 2017–2018 · strength 0.37
  6. Lindsay A. Bliss · 5 shared papers, 2016–2017 · strength 0.35
  7. Mark P. Callery · 5 shared papers, 2016–2018 · strength 0.34
  8. Tara Sotsky Kent · 4 shared papers, 2016–2018 · strength 0.26
  9. Arthur James Moser · 3 shared papers, 2016–2018 · strength 0.19
  10. Anand Mahadevan · 3 shared papers, 2016–2017 · strength 0.19
  11. Subhajyoti De · 1 shared paper, 2023 · strength 0.17
  12. Colin M. Court · 1 shared paper, 2023 · strength 0.17
  13. H. Richard Alexander · 1 shared paper, 2023 · strength 0.17
  14. Joshua D. Greendyk · 1 shared paper, 2023 · strength 0.17
  15. Brett Logan Ecker · 1 shared paper, 2023 · strength 0.17
  16. Eliza Wright Beal · 1 shared paper, 2022 · strength 0.16
  17. Alexander L. Vahrmeijer · 2 shared papers, 2016–2018 · strength 0.14
  18. Rebecca Anne Miksad · 2 shared papers, 2016–2017 · strength 0.13
  19. Joseph Douglas Mancias · 1 shared paper, 2017 · strength 0.07
  20. Robert A. Wolff · 1 shared paper, 2016 · strength 0.06
  21. Douglas B. Evans · 1 shared paper, 2016 · strength 0.06
  22. Alessandra Storino · 1 shared paper, 2016 · strength 0.06
  23. Bert A. Bonsing · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.